Yayınlar & Eserler

Yayın Ağı
Makaleler 17
Tümü (17)
SCI-E, SSCI, AHCI (15)
SCI-E, SSCI, AHCI, ESCI (17)
ESCI (2)
Scopus (17)
TRDizin (3)

1. Evaluation of Bone Mineral Metabolism in Pre-Dialysis Chronic Kidney Disease: Quantitative Computed Tomography vs. Dual-Energy Absorptiometry and Correlation with Bone Turnover Markers

Mutis Alan A., SEZER Z., ÖZ A., Karaca C., Dinçer M. T., MURT A., et al.
Medicina (Lithuania) , cilt.61, sa.1, 2025 (SCI-Expanded) identifier identifier

2. Epidemiological analysis of the victıms wıth crush syndrome in earthquakes of southeastern Turkey

Ozturk I., Gungor O., Ozturk S., Olmaz R., Keskin A. J. G., KOÇYİĞİT İ., et al.
Journal of Nephrology , cilt.37, sa.9, ss.2589-2599, 2024 (SCI-Expanded) identifier identifier identifier

3. Patients with crush syndrome and kidney disease: lessons learned from the earthquake in Kahramanmaraş, Türkiye

Ozturk S., TUĞLULAR Z. S., Olmaz R., KOÇYİĞİT İ., Kibar M. U., Turgutalp K., et al.
Kidney International , cilt.106, sa.5, ss.771-776, 2024 (SCI-Expanded) identifier identifier

4. Post-COVID-19 Outcomes of Patients with Primary Glomerular Diseases: A Nationwide Controlled Study

Öztürk S., Karadağ S., ARICI M., Türkmen A., Turgutalp K., Aktaş N., et al.
Turkish Journal of Nephrology , cilt.33, sa.2, ss.179, 2024 (ESCI) Sürdürülebilir Kalkınma identifier

5. Sarcopenia, an overlooked diagnosis in kidney transplant recipients

Ozcan S. G., Sonmez O., Atli Z., Karaca C., Alagöz S., Akman Z., et al.
Clinical Nephrology , cilt.101, sa.2, ss.59-70, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

6. Humoral Response to BNT162b2 and CoronaVac in Patients Undergoing Maintenance Hemodialysis: A Multicenter Prospective Cohort Study

Mirioglu Ş., Kazancıoğlu R., Cebeci E., Eren N., Sakaci T., Alagoz S., et al.
NEPHRON , cilt.147, sa.7, ss.392-400, 2023 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

7. Demographic, clinical and laboratory characteristics of adult-onset minimal change disease in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working Group

Aydin Z., Yilmaz M., Sipahioglu M., DERVİŞOĞLU E., Aydemir N., Uzun S., et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.55, sa.4, ss.975-982, 2023 (SCI-Expanded) identifier identifier identifier

8. Clinical and pathologic features of primary membranous nephropathy in Turkey: a multicenter study by the Turkish Society of Nephrology Glomerular Diseases Working Group

YILDIZ A., Ulu S., ORUÇ A., Ucar A. R., Ozturk S., Alagoz S., et al.
RENAL FAILURE , cilt.44, sa.1, ss.1048-1059, 2022 (SCI-Expanded) identifier identifier identifier

9. To what extent can we achieve mineral bone metabolism treatment targets suggested by the KDIGO guidelines among chronic kidney disease stage 3-5 non-dialysis patients?

Dincer M. T., ÖZCAN Ş. G., Alagoz S., Karaca C., Gulcicek S. H., TRABULUS S., et al.
CLINICAL NEPHROLOGY , cilt.98, sa.5, ss.239-246, 2022 (SCI-Expanded) identifier identifier identifier

10. The impact of the COVID-19 pandemic on Fabry Disease Patients: an examination of Mood Status, Therapy Adherence, and COVID-19 infection

Karaca C., Dincer M. T., ÖZCAN Ş. G., Sarac B., AHMADZADA S., Alagoz S., et al.
ORPHANET JOURNAL OF RARE DISEASES , cilt.17, sa.1, 2022 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

11. Impact of COVID-19 lockdown on mood status: A comparison of hemodialysis and oncology patients

Alagoz S., EREN N., ÖZCAN Ş. G., Atli Z., Ozkul O., Belli H., et al.
THERAPEUTIC APHERESIS AND DIALYSIS , cilt.26, sa.4, ss.781-789, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

12. The Prevalence of Potential Drug-Drug Interactions in CKD-A Retrospective Observational Study of Cerrahpasa Nephrology Unit

BUKHARI A., Sonmez I., Kose C., OKTAN B., Alagoz S., Sonmez H., et al.
MEDICINA-LITHUANIA , cilt.58, sa.2, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

13. Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk

VELİOĞLU A., Alagoz S., Atas D. B., ARIKAN İ. H., AŞICIOĞLU E., AKSU M. B., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.4, ss.1404-1407, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier identifier

14. Reflex Decay Test Can Reveal Ear Involvement in Fabry Disease

KIYKIM E., Kaya M., DİNCER M. T., Bakir A., Alagoz S., AKTUĞLU ZEYBEK A. Ç., et al.
EAR AND HEARING , cilt.42, sa.5, ss.1351-1357, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

15. THE IMPACT OF THE COVID-19 PANDEMIC ON MOOD STATUS AND TREATMENT ADHERENCE IN PATIENTS WITH FABRY DISEASE

DİNCER M. T., KARACA C., Sarac B., AHMADZADA S., Bakir A., Alagoz S., et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.36, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

16. Clinical Features and Outcomes of Patients with Granulomatosis with Polyangiitis and Review of Literature

Arslan E., Oruc M., Yalin S. F., Alagoz S., Demir H., HATEMİ G., et al.
TURKISH JOURNAL OF NEPHROLOGY , cilt.29, sa.4, ss.279-288, 2020 (ESCI) identifier identifier

17. Prevalence of anemia in predialysis chronic kidney disease: Is the study center a significant factor?

Alagoz S., DİNCER M. T., EREN N., Bakir A., PEKPAK M., TRABULUS S., et al.
PLOS ONE , cilt.15, sa.4, 2020 (SCI-Expanded) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 5

1. EVALUATION OF BONE MINERAL STATUS WITH DUAL-ENERGY X-RAY ABSORPTIOMETRY AND QUANTITATIVE COMPUTED TOMOGRAPHY IN CHRONIC RENAL DISEASE

Alan A. M., SEZER Z., Dincer M. T., ÖZ A., Karaca C., Alagoz S., et al.
60th ERA Congress, Milan, İtalya, 15 - 18 Haziran 2023, (Özet Bildiri) identifier

2. MEMBRANOUS NEPHROPATHY IN TURKEY: TURKISH SOCIETY OF NEPHROLOGY GLOMERULER DISEASES (TSN-GOLD) DATABASE RESULTS

YILDIZ A., ULU M. S., ORUÇ A., Ucar A. R., Ozturk S., Alagoz S., et al.
57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 Haziran 2020, cilt.35, ss.734, (Özet Bildiri) identifier

3. ADULT MINIMAL CHANGE DISEASE IN TURKEY: THE RESULTS OF TURKISH SOCIETY OF NEPHROLOGY GLOMERULAR DISEASES WORKING GROUP

Yilmaz M., Sipahioglu M., DERVİŞOĞLU E., Aydemir N., Uzun S., Istemihan Z., et al.
57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 Haziran 2020, cilt.35, ss.768, (Özet Bildiri) identifier

4. TO WHAT EXTENT CAN WE ACHIEVE MINERAL BONE METABOLISM TREATMENT TARGETS AS SUGGESTED BY UPDATED 2017 KDIGO GUIDELINES IN PATIENTS WITH PREDIALYSIS CHRONIC KIDNEY DISEASE

DİNCER M. T., Ozcan E. G., Alagoz S., KARACA C., Gulcicek S., TRABULUS S., et al.
57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 Haziran 2020, cilt.35, ss.1212 identifier

5. Cerrahpaşa tıp fakültesi renal transplantasyon ünitesinde son dönem böbrek yetmezliği tanılı hastalarda ilaç etkileşmlerinin değerlendirilmesi

SONMEZ I., SHAHZADI A., Karakulak C., ALAGÖZ S., SEYAHİ N., AKKAN A. G.
23. Ulusal Farmakoloji Kongresi, Ankara, Türkiye, 7 - 10 Eylül 2015, sa.14, ss.109
Metrikler

Yayın

22

Yayın (WoS)

21

Yayın (Scopus)

17

Atıf (WoS)

5

H-İndeks (WoS)

1

Atıf (Scopus)

9

H-İndeks (Scopus)

2

Açık Erişim

4
BM Sürdürülebilir Kalkınma Amaçları